For the three months ended March 31, 2026 and 2025, our potentially dilutive securities included stock options, restricted stock units, performance stock units, shares to be issued under our employee stock purchase plan (“ESPP”) and contingently issuable shares related to our short-term incentive compensation program.

The following table sets forth the calculation of basic and diluted income per share for the three months ended March 31, 2026 and 2025:


	Three Months Ended March 31,
	2026		2025
Net income	$	88,098	$	76,142

Weighted-average common shares outstanding – basic	221,853		211,958
Dilutive effect of stock-based compensation awards	5,601		11,661
Weighted-average common shares outstanding – diluted	227,454		223,619

Income per common share – basic	$	0.40	$	0.36
Income per common share – diluted	$	0.39	$	0.34

The following is a summary of potential shares of common stock that were antidilutive and excluded from the weighted average share computations for the three months ended March 31, 2026 and 2025:


	Three Months Ended March 31,
	2026	2025
Stock options	28	37
Restricted stock units	556	2
Performance stock units	159	—
ESPP shares	96	—
Potential common shares excluded from the weighted average share calculations	839	39